United States · Biotechnology startup
United States · NxThera
NxThera develops medical technologies to treat a variety of endourology conditions, including BPH.
Funding reportedLast round: Debt financing
Follow NxThera and see its new rounds in your feed.Start following
What company datasets say NxThera raised
Funding, as reported
Reported in all$123Min dollars
Rounds8
Last roundDebt financing
Last round dateJul 2017
Investors listed7
SEC Form D$126M sold, 14 filings, last Jul 2017
Founders and team
From the SEC filings it signed: 7 on the team.
- Carmen B. VolkhartExecutive Officeri
- Cindy B. OgdenExecutive Officeri
- J. Robert PaulsonExecutive Officer, Directori
- Michael B. KujakExecutive Officeri
- Michael Robert HoeyExecutive Officer, Directori
- Mona B. DahdahExecutive Officeri
- Patrick B. FabianExecutive Officeri
On the board, as filediAndre Robert de BruinBrian Robert GustafsonCharles Robert ChonJan Robert GarfinkleSami Robert HamadeSigrid Robert VanBladelTom Robert Lowe
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put NxThera in front of investors. Or tell us what we have wrong.